These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28223538)

  • 1. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
    Ayinde O; Wang Z; Griffin M
    Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.
    Fisher ML; Adhikary G; Xu W; Kerr C; Keillor JW; Eckert RL
    Oncotarget; 2015 Aug; 6(24):20525-39. PubMed ID: 25971211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.
    Condello S; Sima L; Ivan C; Cardenas H; Schiltz G; Mishra RK; Matei D
    Cancer Res; 2018 Jun; 78(11):2990-3001. PubMed ID: 29510995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.
    Ayinde O; Wang Z; Pinton G; Moro L; Griffin M
    Oncotarget; 2019 Jul; 10(44):4556-4569. PubMed ID: 31360304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
    Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
    Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
    Ning X; Wang C; Zhang M; Wang K
    Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase is a tumor cell and cancer stem cell survival factor.
    Eckert RL; Fisher ML; Grun D; Adhikary G; Xu W; Kerr C
    Mol Carcinog; 2015 Oct; 54(10):947-58. PubMed ID: 26258961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
    Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
    Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Kang S; Oh SC; Min BW; Lee DH
    Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
    Cao L; Shao M; Schilder J; Guise T; Mohammad KS; Matei D
    Oncogene; 2012 May; 31(20):2521-34. PubMed ID: 21963846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
    Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
    Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation.
    Rapetti-Mauss R; Bustos V; Thomas W; McBryan J; Harvey H; Lajczak N; Madden SF; Pellissier B; Borgese F; Soriani O; Harvey BJ
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4159-4164. PubMed ID: 28373572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
    Agnihotri N; Mehta K
    Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis.
    Nyabam S; Wang Z; Thibault T; Oluseyi A; Basar R; Marshall L; Griffin M
    Biochim Biophys Acta; 2016 Sep; 1863(9):2234-44. PubMed ID: 27234323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.